Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Meshalkin Research Institute Of Pathology Of Circulation

Clinical trials sponsored by Meshalkin Research Institute Of Pathology Of Circulation, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pacing technique aims to prevent heart failure in High-Risk HCM patients Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 2

New pacing technique aims to prevent heart failure in High-Risk HCM patients

Disease control Recruiting now

This study compares a new pacing method (left bundle branch pacing) with a standard pacemaker-defibrillator in 30 people who have hypertrophic cardiomyopathy and a specific heart block after myectomy surgery. The goal is to see if the new method better prevents heart failure wors…

Sponsor: Meshalkin Research Institute of Pathology of Circulation • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC